Clinical trial · Observational
An In-situ Detection for MicroRNA
A New Detection Method for MicroRNA in Patients With Breast Cancer
NCT06529614CI-TRIAL-00096331recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| In-situ detection for Micro-RNA | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Health donor group
- interventionNames
- Other: In-situ detection for Micro-RNA
- label
- Breast cancer group
- interventionNames
- Other: In-situ detection for Micro-RNA
Primary outcomes (1)
- measure
- Sensitivity and specificity of test
- timeFrame
- 8 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: Healthy without serious diseases \- Exclusion Criteria: * situations that may affect the results
References
Publications (0)
Data not yet available
No reference posted for this study.